Press Releases and News
Pluristyx and Accelerated Biosciences announce availability of clinical-grade immune-privileged human trophoblast stem cells (hTSCs)
April 27, 2022
Pluristyx announces strategic alliance with panCELLa and Implant Therapeutics of offer 'off-the-shelf' induced pluripotent stem cells.
January 20, 2022
Accelerated Biosciences’ Immune-Privileged Human Trophoblast Stem Cells (hTSCs) Offer Breakthrough Opportunities in Cancer-Targeting Therapeutics and Regenerative Medicine Treatments
May 11, 2021
AgeX Therapeutics and Pluristyx Announce Manufacturing, Marketing, and Distribution Agreement to Expand Access to Clinical-Grade Human Pluripotent Stem Cells for Therapeutic Applications
June 16, 2020